Indeed, silencing of ARID1A and ARID1B in the APL cell line NB4 impaired differentiation in response to ATRA treatment, suggesting the pivotal role of these genes in the differentiation process toward the granulocytic lineage.15, 22. The gene discussed is ARID1B; the disease is acute promyelocytic leukemia.